Ventilator-associated tracheobronchitis and pneumonia: Thinking outside the Box

Clinical Infectious Diseases

Volumn 51, Issue SUPPL. 1, 2010, Pages

  Craven, Donald E ^a   Hjalmarson, Karin I ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BACTERIAL ENZYME; CARBEPENEMASE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; UNCLASSIFIED DRUG; VANCOMYCIN; ANTIINFECTIVE AGENT;

ACINETOBACTER BAUMANNII; ANTIBIOTIC THERAPY; ARTERIAL OXYGEN TENSION; ARTIFICIAL VENTILATION; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BURKHOLDERIA CEPACIA; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC APPROACH ROUTE; EPIDEMIOLOGICAL DATA; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM NEGATIVE INFECTION; GRAM POSITIVE BACTERIUM; GRAM POSITIVE INFECTION; GRAM STAINING; HAEMOPHILUS INFLUENZAE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; LENGTH OF STAY; LOWER RESPIRATORY TRACT INFECTION; LUNG INFILTRATE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIXED INFECTION; MULTIDRUG RESISTANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK REDUCTION; STENOTROPHOMONAS MALTOPHILIA; THORAX RADIOGRAPHY; TRACHEAL ASPIRATION PROCEDURE; TRACHEOBRONCHITIS; TREATMENT DURATION; TREATMENT INDICATION; VENTILATOR; VENTILATOR ASSOCIATED PNEUMONIA; VENTILATOR ASSOCIATED TRACHEOBRONCHITIS; BACTERIA; BRONCHITIS; CROSS INFECTION; DRUG EFFECTS; HOSPITAL; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; TIME; TRACHEITIS;

ANTI-BACTERIAL AGENTS; BACTERIA; BRONCHITIS; CROSS INFECTION; HOSPITALS; HUMANS; MICROBIAL SENSITIVITY TESTS; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; TIME FACTORS; TRACHEITIS;

EID: 77955683345     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/653051     Document Type: Conference Paper

References (32)

1. Niederman MS, Craven DE, Bonten MJ. American Thoracic Society and Infectious Diseases Society of America (ATS/IDSA). Guideline for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005; 171:388-416.
2. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002; 165:867-903.
3. Nseir S, Di Pompeo C, Pronnier P, et al. Nosocomial tracheobronchitis in mechanically ventilated patients: incidence, aetiology and outcome. Eur Respir J 2002; 20:1483-1489.
4. Nseir S, Favory R, Jozefowicz E, et al. Antimicrobial treatment for ventilator-associated tracheobronchitis: a randomized controlled mul-ticenter study. Crit Care 2008; 12:R62.
5. Craven DE, Chroneou A, Zias N, et al. Ventilator-associated trache-obronchitis: the impact of targeted antibiotic therapy on patient outcomes. Chest 2009; 135:521-528.
6. Nseir S, Di Pompeo C, Soubrier S, et al. Effect of ventilator-associated tracheobronchitis on outcome in patients without chronic respiratory failure: a case-control study. Crit Care 2005; 9:R238-245.
7. Palmer LB, Smaldone GC, Chen JJ, et al. Aerosolized antibiotics and ventilator-associated tracheobronchitis in the intensive care unit. Crit Care Med 2008; 36:2008-2013.
8. Dallas J, Kollef M. VAT vs VAP: are we heading toward clarity or confusion? Chest 2009; 135:252-255.
9. A'Court CH, Garrard CS, Crook D, et al. Microbiological lung surveillance in mechanically ventilated patients, using non-directed bronchial lavage and quantitative culture. Q J Med 1993; 86:635-648.
10. Torres A, Valencia M. Does ventilator-associated tracheobronchitis need antibiotic treatment? Crit Care 2005; 9:255-256.
11. Rello J, Ollendorf DA, Oster G, et al. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002; 122:2115-2121.
12. Kollef MH, Afessa B, Anzueto A, et al. Silver-coated endotracheal tubes and incidence of ventilator-associated pneumonia: the NASCENT randomized trial. JAMA 2008; 300:805-813.
13. El Solh AA, Akinnusi ME, Wiener-Kronish JP, et al. Persistent infection with Pseudomonas aeruginosa in ventilator associated pneumonia. Am J Respir Crit Care Med 2008; 178:513-519.
14. Craven DE. Preventing ventilator-associated pneumonia in adults: sowing seeds of change. Chest 2006; 130:251-260.
15. Torres A, Ewig S. Diagnosing ventilator-associated pneumonia. N Engl J Med 2004; 350:433-435.
16. Klompas M. Does this patient have ventilator-associated pneumonia? JAMA 2007; 297:1583-1593.
17. Klompas M, Kulldorff M, Platt R. Risk of misleading ventilator-associated pneumonia rates with use of standard clinical and microbiological criteria. Clin Infect Dis 2008; 46:1443-1446.
18. Graat ME, Choi G, Wolthuis EK, et al. The clinical value of daily routine chest radiographs in a mixed medical-surgical intensive care unit is low. Crit Care 2006; 10:R11.
19. Syrjala H, Broas M, Suramo I, et al. High-resolution computed tomography for the diagnosis of community-acquired pneumonia. Clin Infect Dis 1998; 27:358-363.
20. Winer-Muram HT, Rubin SA, Ellis JV, et al. Pneumonia and ARDS in patients receiving mechanical ventilation: diagnostic accuracy of chest radiography. Radiology 1993; 188:479-485.
21. Nseir S, Di Pompeo C, Soubrier S, et al. Impact of ventilator-associated pneumonia on outcome in patients with COPD. Chest 2005; 128: 1650-1656.
22. Michel F, Franceschini B, Berger P, et al. Early antibiotic treatment for BAL-confirmed ventilator-associated pneumonia: a role for routine endotracheal aspirate cultures. Chest 2005; 127:589-597.
23. Depuydt P, Benoit D, Vogelaers D, et al. Systematic surveillance cultures as a tool to predict involvement of multidrug antibiotic resistant bacteria in ventilator-associated pneumonia. Intensive Care Med 2008; 34: 675-682.
24. Hayon J, Figliolini C, Combes A, et al. Role of serial routine micro-biologic culture results in the initial management of ventilator- associated pneumonia. Am J Respir Crit Care Med 2002; 165:41-46.
25. Yang K ZH, Guglielmo BJ, Wiener-Kronish J. Multidrug-resistant Pseu-domonas aeruginosa ventilator-associated pneumonia: The role of en-dotracheal aspirate surveillance cultures. Ann Pharmacother 2009; 43: 28-35.
26. Ibrahim EH, Ward S, Sherman G, et al. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Crit Care Med 2001; 29:1109-1115.
27. Rello J, Valles J. Mortality as an outcome in hospital-acquired pneumonia. Infect Control Hosp Epidemiol 1998; 19:795-797.
28. Sanchez-Nieto JM, Torres A, Garcia-Cordoba F, et al. Impact ofinvasive and noninvasive quantitative culture sampling on outcome of ventilator- associated pneumonia: a pilot study. Am J Respir Crit Care Med 1998; 157:371-376.
29. Nseir S, Di Pompeo C, Soubrier S, et al. Outcomes of ventilated COPD patients with nosocomial tracheobronchitis: a case-control study. Infection 2004; 32:210-216.
30. Nseir S, Ader F, Marquette CH, et al. Impact of fluoroquinolone use on multidrug-resistant bacteria emergence [in French]. Pathol Biol (Paris) 2005; 53:470-475.
31. Singh N, Rogers P, Atwood CW, et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. Am J Respir Crit Care Med 2000; 162:505-511.
32. Lisboa T, Craven DE, Rello J. Safety in critical care and pulmonary medicine: should VAP be a quality indicator for patient safety? Clin Pulmon Med 2009;16:28-31.